MX9603045A - Antagonistas de los receptores endoteliales. - Google Patents

Antagonistas de los receptores endoteliales.

Info

Publication number
MX9603045A
MX9603045A MX9603045A MX9603045A MX9603045A MX 9603045 A MX9603045 A MX 9603045A MX 9603045 A MX9603045 A MX 9603045A MX 9603045 A MX9603045 A MX 9603045A MX 9603045 A MX9603045 A MX 9603045A
Authority
MX
Mexico
Prior art keywords
receptor antagonists
endothelial receptor
endothelial
salts
show
Prior art date
Application number
MX9603045A
Other languages
English (en)
Inventor
Mathias Osswald
Dieter Dorsch
Werner Mederski
Claudia Wilm
Claus J Schmitges
Maria Christadler
Original Assignee
Merck Patent Gmbh
Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Haftung filed Critical Merck Patent Gmbh
Publication of MX9603045A publication Critical patent/MX9603045A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos compuestos de la formula I (Ver Formula) donde -Y-Z-, R1, R2, R3, R4, R5 y X tienen los significados indicados en la reivindicacion 1, y las sales, de estos compuestos, presentan propiedades antagonistas de los receptores de endotelina.
MX9603045A 1995-07-28 1996-07-26 Antagonistas de los receptores endoteliales. MX9603045A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19527568A DE19527568A1 (de) 1995-07-28 1995-07-28 Endothelin-Rezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
MX9603045A true MX9603045A (es) 1997-01-31

Family

ID=7767990

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603045A MX9603045A (es) 1995-07-28 1996-07-26 Antagonistas de los receptores endoteliales.

Country Status (16)

Country Link
US (1) US5700807A (es)
EP (1) EP0755934A1 (es)
JP (1) JPH0940678A (es)
KR (1) KR970006305A (es)
AU (1) AU6060796A (es)
BR (1) BR9603164A (es)
CA (1) CA2182156A1 (es)
CZ (1) CZ219796A3 (es)
DE (1) DE19527568A1 (es)
HU (1) HUP9602054A3 (es)
MX (1) MX9603045A (es)
NO (1) NO963131L (es)
PL (1) PL315422A1 (es)
SK (1) SK92496A3 (es)
TW (1) TW367328B (es)
ZA (1) ZA966399B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291442B1 (en) 1998-02-03 2001-09-18 The General Hospital Corporation Pharmacological modulators of voltage-gated potassium ion channels
IL125659A (en) † 1998-08-05 2002-09-12 Cadent Ltd Method and device for three-dimensional simulation of a structure
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
EP1465869B1 (en) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1487813B1 (en) * 2002-02-22 2006-08-30 Bayer Pharmaceuticals Corporation Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
NZ545805A (en) * 2003-08-29 2009-12-24 Ono Pharmaceutical Co Compound capable of binding S1P receptor and pharmaceutical use thereof
WO2015088564A1 (en) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
RU2086544C1 (ru) 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
RU2125980C1 (ru) 1991-11-05 1999-02-10 Смитклайн Бичам Корпорейшн Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
ZA939516B (en) 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DE69422742T2 (de) 1993-03-19 2000-08-17 Merck & Co Inc Phenoxyphenylessigsäurederivate
EP0763035A4 (en) * 1994-06-09 1997-10-01 Smithkline Beecham Corp ENDOTHELIN RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
ZA966399B (en) 1997-02-19
PL315422A1 (en) 1997-02-03
HUP9602054A2 (en) 1997-11-28
EP0755934A1 (en) 1997-01-29
HUP9602054A3 (en) 1998-07-28
AU6060796A (en) 1997-02-06
KR970006305A (ko) 1997-02-19
JPH0940678A (ja) 1997-02-10
CZ219796A3 (en) 1997-02-12
NO963131D0 (no) 1996-07-26
HU9602054D0 (en) 1996-09-30
US5700807A (en) 1997-12-23
BR9603164A (pt) 1998-05-05
TW367328B (en) 1999-08-21
CA2182156A1 (en) 1997-01-29
NO963131L (no) 1997-01-29
DE19527568A1 (de) 1997-01-30
SK92496A3 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
SG45486A1 (en) Pyrimidinedione pyrimidinetrione truazubeduione tetrahydro-quinazolinedione derivatives as alpha 1 adrenergic receptor antagonists
NZ307625A (en) 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
HUT70441A (en) Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties and pharmaceutical compositions comprising them
MA22758A1 (fr) Antagonistes des recepteurs d'endotheline
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
HK1008819A1 (en) Piperidine derivatives as neurokinin antagonists
ATE480252T1 (de) Peptidantagonist von zonulin und dessen verwendung
MX9805255A (es) Antagonistas de receptor de vitronectina.
BG103548A (en) Vitronectine receptor antagonists
ZA9610736B (en) 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
EP0810994A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
MA23172A1 (fr) Antagonistes de recepteurs d'endotheline .
EP0866705A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
BG104916A (en) Calcilytic compounds
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
BG102589A (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists
CY2198B1 (en) 1-Aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
MX9603045A (es) Antagonistas de los receptores endoteliales.
AU9069191A (en) Use of angiotensin ii receptor antagonists in the prevention of restinosis
EP0714295A4 (es)
EP1246619A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
MX9603199A (es) Antagonistas de receptores a endotelina.
BG103502A (en) Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists